Medicare AdvantageCoverageMedium impact
MA00.002r, Continuous Glucose Monitors and Home Blood Glucose Monitors and Supplies
Independence Blue Cross·Endocrinology, Family Medicine, Internal Medicine +1 more·Medical Policy
Effective date
Apr 1, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA00.002r for Continuous Glucose Monitors and Home Blood Glucose Monitors and Supplies has been updated, effective April 1, 2025. This policy change affects billing and coverage requirements for glucose monitoring devices and supplies for Medicare Advantage beneficiaries.
Action Required
By April 1, 2025: Review updated Medicare Advantage policy MA00.002r for continuous glucose monitors and home blood glucose monitors and supplies. Billing team should verify current coverage requirements and any changes to prior authorization, documentation, or billing procedures for glucose monitoring devices. Update billing workflows to comply with new policy requirements to avoid claim denials.